The Royal National Orthopaedic Hospital NHS Trust (RNOH) has rolled out new features via Open Medical’s Pathpoint platform which includes digitising referral management, consent and patient-reported outcome measures.
RNOH initially implemented Open Medical’s Pathpoint at the start of the Covid pandemic and recently went live with its Streamlining Processes to Achieve Clinical Excellence through Digitisation (SPACED) project. The project will focus on streamlining referral management; digital consent, and patient-reported outcome measures (PROM) initially and will cover 15 sub-specialities and 50 different pathways.
This will mean all urgent, and non-urgent referrals to the Royal National Orthopaedic Hospital will be captured by Pathpoint’s single unified portal. This real-time clinical data is then integrated with the eRS national referral system.
This integration means that trust clinicians can improve the referral triage process and help ensure that patients are seen as quickly as possible, regardless of where in the country the referral came from.
The cloud-based software uses advanced natural language processing, so that clinical information is coded at the point of entry using SNOMED-CT terminology. This helps to improve reporting capabilities and generate meaningful care metrics which can be used to support future service planning.
Dr Lila Dinner, deputy chief executive and chief medical officer/CCIO at the trust, said: “The new Pathpoint referral platform will be a huge benefit to our patients – and staff. We’re continually seeking ways to improve the patient experience at the RNOH and a key part of that is sourcing new and improved systems that allow us to respond better and quicker.
“Pathpoint will allow us to streamline and manage referrals and utilise patient-reported outcome measures. The end result will not only be a better patient experience, but a better staff experience too.”
Pre-pandemic, the Royal National Orthopaedic Hospital also signed a deal with Interneuron CIC to replace its legacy technology with a newer clinical data platform.